4//SEC Filing
Domzalski David 4
Accession 0001415889-25-000152
CIK 0001566044other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:45 PM ET
Size
5.2 KB
Accession
0001415889-25-000152
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Tax Payment
Common Stock
2024-12-31$3.35/sh−24,536$82,196→ 476,061 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727794
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 5:45 PM ET
- Size
- 5.2 KB